EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease

Chunyan Niu, Wen Gao, Mei Tan, Yue Chen, Yongqiang Shi, Yan Geng, Huayi Tao, Zhenjiang Xu, Tingting Zhang, Jinming Yang

Journal of Materials Chemistry B · 2026 · 14 (13) · 4173-4182

DOI: 10.1039/d5tb02289d ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Materials Chemistry B, 2026. Verfasst von Chunyan Niu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China. nchy6…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Galactose, Nanoparticles, Sulfonamides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau, LiShui People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The MCC950-loaded formulation effectively reduced the expression of inflammatory regulators and cytokines associated with the NF-κB/NLRP3-related signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinGalactoseNanoparticlesSulfonamidesFatty LiverInflammationFuransLipidsSulfonesAnimalsMiceHumansHeterocyclic Compounds, 4 or More RingsMaleMice, Inbred C57BLParticle SizeIndenesLiposomes

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinGalactoseSulfonamidesHeterocyclic Compounds, 4 or More RingsFuransLipidsSulfonesN-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamideNlrp3 protein, mouseLipid Nanoparticles

Autor:innen und Institutionen

  • Department of Gastroenterology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China. nchy69@163.com.
  • Department of Endocrinology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China.
  • Endoscopy Center, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, 211200, China. 2389121017@qq.com.

Förderung

  • Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau
  • LiShui People's Hospital

Zitieren

APA

Niu, C., Gao, W., Tan, M., Chen, Y., Shi, Y., Geng, Y., Tao, H., Xu, Z., Zhang, T., & Yang, J. (2026). Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease. Journal of Materials Chemistry B, 14(13), 4173-4182. https://doi.org/10.1039/d5tb02289d

Vancouver

Niu C, Gao W, Tan M, Chen Y, Shi Y, Geng Y, et al. Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease. Journal of Materials Chemistry B. 2026;14(13):4173-4182. doi:10.1039/d5tb02289d

BibTeX
@article{Niu2026,
  author = {Niu, Chunyan and Gao, Wen and Tan, Mei and Chen, Yue and Shi, Yongqiang and Geng, Yan and Tao, Huayi and Xu, Zhenjiang and Zhang, Tingting and Yang, Jinming},
  title = {Galactose-decorated lipid nanoparticle-mediated delivery of a selective NLRP3 inhibitor attenuates hepatic inflammation in metabolic dysfunction-associated steatotic liver disease},
  journal = {Journal of Materials Chemistry B},
  year = {2026},
  volume = {14},
  number = {13},
  pages = {4173--4182},
  doi = {10.1039/d5tb02289d}
}
Kostenlos starten →